NASDAQ:TWST • US90184D1000
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TWIST BIOSCIENCE CORP (TWST).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-03 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-03 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-26 | Guggenheim | Maintains | Buy -> Buy |
| 2026-01-08 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-15 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-04 | Stephens & Co. | Initiate | Overweight |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-06 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-05-06 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-05-06 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-06 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-04 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-04 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-02-04 | Baird | Maintains | Outperform -> Outperform |
| 2024-12-13 | Wolfe Research | Initiate | Outperform |
| 2024-11-26 | TD Cowen | Reiterate | Buy -> Buy |
| 2024-11-19 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-19 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-19 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-17 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2024-10-01 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-05 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 245.1M 20.38% | 312.974M 27.69% | 376.572M 20.32% | 447.8M 18.91% | 515.3M 15.07% | 595.12M 15.49% | 677.69M 13.87% | 779.59M 15.04% | |
| EBITDA YoY % growth | -171.69M 21.35% | -144.469M 15.85% | -111.406M 22.89% | -42.118M 62.19% | -6.609M 84.31% | 24.737M 474.30% | 51.918M 109.88% | 119.65M 130.46% | |
| EBIT YoY % growth | -201M 14.40% | -175.901M 12.49% | -136.259M 22.54% | -113.994M 16.34% | -86.64M 24.00% | -52.481M 39.43% | 18.513M 135.28% | 68.34M 269.15% | |
| Operating Margin | -82.01% | -56.20% | -36.18% | -25.46% | -16.81% | -8.82% | 2.73% | 8.77% | |
| EPS YoY % growth | -3.37 16.38% | -3.60 -6.82% | -2.11 41.39% | -1.84 12.86% | -1.33 27.57% | -0.79 40.69% | N/A | N/A |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.49 26.09% | -0.40 14.57% | -0.32 29.43% | -0.40 20.95% | -0.36 26.29% | -0.30 25.70% | -0.26 19.70% |
| Revenue Q2Q % growth | 109.81M 18.34% | 113.65M 18.32% | 117.67M 18.85% | 119.24M 14.99% | 122.99M 12.00% | 127.61M 12.28% | 133.89M 13.78% |
| EBITDA Q2Q % growth | -7.685M 73.29% | -4.209M 62.66% | 1.382M 127.20% | -6.359M 76.19% | -907.8K 88.19% | 7.283M 273.05% | 10.643M 670.12% |
| EBIT Q2Q % growth | -31.348M 24.57% | -26.615M 11.64% | -22.519M 24.77% | -28.119M 14.53% | -24.555M 21.67% | -20.076M 24.57% | -17.833M 20.81% |
All data in USD
17 analysts have analysed TWST and the average price target is 51.61 USD. This implies a price increase of 6.11% is expected in the next year compared to the current price of 48.64.
TWIST BIOSCIENCE CORP (TWST) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of TWIST BIOSCIENCE CORP (TWST) is -0.49 USD and the consensus revenue estimate is 109.81M USD.
The expected long term growth rate for TWIST BIOSCIENCE CORP (TWST) is 15.91%.